Assessment of Anti‐Xa activity in patients receiving concomitant apixaban with strong p‐glycoprotein inhibitors and statins
Author:
Affiliation:
1. Dwight D. Eisenhower Army Medical Center Ft Gordon Georgia USA
2. Department of Chemistry and Life Science United States Military Academy West Point New York USA
3. Department of Medicine Uniformed Services University Bethesda Maryland USA
Publisher
Hindawi Limited
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13596
Reference31 articles.
1. Apixaban: A novel oral inhibitor of factor Xa
2. The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue
3. Laboratory monitoring of direct oral anticoagulants (DOACs) ‐ The perfect storm?;Giuseppe Lippi EF;Ann Transl Med,2017
4. An update on laboratory assessment for direct oral anticoagulants (DOACs)
5. Eliquis (apixaban). Package insert. Bristol Myers Squibb.2012.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration;Drug Resistance Updates;2024-09
2. Does amiodarone impact on apixaban levels? The effect of amiodarone on apixaban level among Thai patients with non-valvular Atrial Fibrillation;PLOS ONE;2024-01-19
3. Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters;Nature Reviews Cancer;2023-09-15
4. DOAC plasma concentration upon hospital admission in a cohort of trauma patients. An observational real-life study;European Journal of Trauma and Emergency Surgery;2023-07-27
5. Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation;Annals of Internal Medicine;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3